Company intelligence / Profile preview

Tibet Everest Shougao Biopharmaceutical

Lhasa, Tibet, China

Ownership: Private
Development stage: Other

Overview

Tibet Everest Shougao Biopharmaceutical is a Chinese biopharmaceutical company focused on the development and commercialization of treatments for metabolic diseases, particularly diabetes and obesity. The company is a joint venture or strategic entity involving Tibet Everest Resources and other investment groups, aimed at leveraging biotechnology for high-growth therapeutic areas. Its primary focus includes the development of long-acting insulin analogs and GLP-1 receptor agonists. The company operates research and manufacturing facilities in China to support its clinical pipeline and future commercial production.

Therapeutic areas: Endocrinology
Modalities: Small moleculeBiologicRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Tibet Everest Shougao Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tibet Everest Shougao Biopharmaceutical.

Explore the full profile